Results 91 to 100 of about 319,380 (216)

Recommendations of the Moroccan Society of Rheumatology (SMR) for the Therapeutic Management of Spondyloarthritis (SpA) including Psoriatic Arthritis (PsA). [PDF]

Mediterr J Rheumatol, 2023
Jaouad N, Oulkadi L, Bentaleb I, Bezza A, Maghraoui AE, Niamane R, Bouchti IE, Larhrissi S, Ichchou L, Janani S, Abourazzak FE, Akasbi N, Erraoui M, Karkouri S, Hmamouchi I, Bahiri R.   +15 more
europepmc   +1 more source

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial

Arthritis &Rheumatology, Volume 78, Issue 10, Page 2089-2101, October 2026.
Objective Overweight or obesity is prevalent in 72% to 82% of individuals with psoriatic arthritis (PsA). We assessed the efficacy and safety of ixekizumab (IXE) concomitantly administered with tirzepatide (TZP) compared with IXE alone in adult participants with active PsA and overweight with at least one weight‐related comorbidity or obesity.
Joseph F. Merola, Philip Mease, Alan Kivitz, Naveed Sattar, Laura C. Coates, Daniel Aletaha, Cynthia E. Kartman, Peter Fischer, Luna Sun, Píndaro Martínez‐Osuna, Andris Kronbergs, Purvi Prajapati, Anabela Cardoso, Mark C. Genovese, Alexis Ogdie   +14 more
wiley   +1 more source

Exploring the Association Between History of Psoriasis (PSO) and Disease Activity in Patients with Psoriatic Arthritis (PsA). [PDF]

Rheumatol Ther, 2022
Li SS, Du N, He SH, Liang X, Li TF.
europepmc   +1 more source

Functional Impact of Structural Damage in Psoriatic Arthritis: Insights from a Prospective Cohort Study

Arthritis &Rheumatology, Volume 78, Issue 10, Page 2102-2109, October 2026.
Objective To examine the association between radiographic structural damage and physical function (PF) in psoriatic arthritis (PsA). Methods Data were analyzed from a large longitudinal PsA cohort. PF was measured using the Health Assessment Questionnaire (HAQ, 0–3) and Short Form‐36 PF subscale (SF‐36, 0–100); radiographic joint damage was measured ...
Pankti Mehta, Shangyi Gao, Virginia Carrizo Abarza, Fadi Kharouf, Daniel Pereira, Richard J. Cook, Dafna D. Gladman, Vinod Chandran, Denis Poddubnyy   +8 more
wiley   +1 more source

Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system – the case of Poland

, 2016
Objective : The objective of the study was to analyse the prevalence of psoriatic arthritis (PsA) in Poland and to assess the costs generated by treatment of PsA patients in the system of public healthcare. Material and methods : The analysis was based
Brygida Kwiatkowska, Andrzej Śliwczyński, Melania Brzozowska, Filip Raciborski, Anna Kłak, Małgorzata Tłustochowicz   +5 more
core   +1 more source

Arthritis Mutilans: Case Report of an Uncommon Squeal of Psoriatic Arthritis

Journal of Bahria University Medical and Dental College, 2021
Psoriatic arthritis (PsA) is a seronegative spondyloarthropathy that presents clinically in different forms. Arthritis mutilans is a rare yet the most aggressive and disabling form of PsA that requires early diagnosis and aggressive therapy preferably ...
Farooq Azam Rathore, Saeed Bin Ayaz
doaj  

Mucosal‐Associated Invariant T Cells in Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao, Feng‐Mi Ou, Dan Liang, Yang Gao, Qing‐Qing Li, Yi‐Qun Kuang   +5 more
wiley   +1 more source

Prevalence of Psoriasis and Psoriatic Arthritis and Patient Perceptions of Severity in Sweden, Norway and Denmark: Results from the Nordic Patient Survey of Psoriasis and Psoriatic Arthritis

Acta Dermato-Venereologica, 2018
Optimal clinical management of psoriasis and psoriatic arthritis (PsA) Optimal clinical management of psoriasis and psoriatic arthritis (PsA) requires understanding of the impact on patients. The NORdic PAtient survey of Psoriasis and PsA (NORPAPP) aimed
Kjersti Danielsen, Albert Duvetorp, Lars Iversen, Mikkel Østergaard, Oliver Seifert, Kåre Steinar Tveit, Lone Skov   +6 more
doaj   +1 more source

TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA). [PDF]

BMJ Open, 2022
Kleinrensink NJ, Perton FT, Pouw JN, Vincken NLA, Hartgring SAY, Jansen MP, Arbabi S, Foppen W, de Jong PA, Tekstra J, Leijten EFA, Spierings J, Lafeber FPJG, Welsing PMJ, Heijstek MW, TOFA-PREDICT author group.   +15 more
europepmc   +1 more source

Usage of C-Reactive Protein Testing in the Diagnosis and Monitoring of Psoriatic Arthritis (PsA): Results from a Real-World Survey in the USA and Europe. [PDF]

Rheumatol Ther, 2022
Ogdie A, Tillett W, Booth N, Howell O, Schubert A, Peterson S, Chakravarty SD, Coates LC.   +7 more
europepmc   +1 more source